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Abstract: In a recent paper, we proposed that a contributing factor in autism is a 
deficiency in cholesterol sulfate supply. In this paper, we investigate a link between 
preeclampsia and subsequent autism in the child, and we hypothesize that both conditions 
can be attributed to a severe depletion of cholesterol sulfate. Through studies on the 
Vaccine Adverse Event Reporting System (VAERS) database, we demonstrate a strong 
statistical relationship among the signs and symptoms associated with autism and those 
associated with preeclampsia, pernicious anemia, and serious adverse reactions to vaccines. 
We show that VAERS reports associated with symptoms typical of pernicious anemia 
produce both a set of symptoms that are highly correlated with preeclampsia and another 
set highly correlated with autism. We explain this observation via an argument that, in a 
severe reaction, the cascade of events subsequent to vaccination reflects a profuse 
production of nitric oxide (NO) and consequential destruction of both red blood cells 
(RBCs) and cobalamin. This may explain the diverse signs and symptoms associated with 
both preeclampsia and severe vaccine adverse reactions. We argue that excess NO 
synthesis, induced by the aluminum and antigen in vaccines, results in hemolysis of RBCs, 
which allows hemoglobin to scavenge the excess NO, converting it to nitrate. The NO is 
also scavenged by cobalamin, leading to its inactivation and contributing to subsequent 
pernicious anemia. Finally, we demonstrate that severe adverse reactions to vaccines can 
be associated with life-threatening conditions related to the heart and brain, as well as 
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stillbirth, when the vaccine is administered to a woman in the third-trimester of pregnancy, 
as demonstrated by statistical analysis of the Gardasil records. 
Keywords: encephalitis; preeclampsia; autism; cobalamin; pernicious anemia; nitric oxide; 
cholesterol sulfate; aluminum; seizures  
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1. Introduction 
Preeclampsia is a serious condition, life-threatening to both the mother and the fetus, which 
typically develops late in pregnancy, associated with hypertension and proteinuria [1,2]. It is estimated 
to affect 6–8% of pregnancies in the U.S. The etiology of preeclampsia remains poorly understood, but 
it is clear that an underlying pathology related to the coagulation cascade is involved, with 
vasoconstrictive factors as secondary effects. Excess free iron in the blood suggests that hemolysis is a 
contributing factor [3]. 
Preeclampsia diagnosed in the mother is highly correlated (p < 0.0001) with a future diagnosis of 
autism for the fetus [4]. We have previously argued [5], that autism may be due to a deficiency in the 
supply of cholesterol sulfate to the fetus, and, subsequently, to the infant postnatally. We further argue 
that it is caused by a deficiency in the supply of critical nutrients, namely cholesterol, zinc and sulfur, 
and in the amount of sunlight exposure to the skin, again, both for the mother and the child. Here, we 
argue further that cobalamin (vitamin B12) deficiency is likely also present, as this nutrient is found 
naturally mainly in animal foods, and is especially enriched in foods containing cholesterol such as 
molluscs, clams, liver, and eggs, which are not likely to be major components of a modern diet. This 
will lead to a tendency towards anemia, which further increases vulnerability to factors that perturb 
blood stability. 
Proteinuria, a strong risk factor for preeclampsia, comes about because the glomeruli of the kidney 
allow large blood proteins like albumin and globulin to pass through a defective filter. Such defective 
filtering in the kidneys has been shown to be a consequence of both a decreased production of heparan 
sulfate and an increased breakdown of heparan sulfate by both reactive oxygen species (ROS) and 
active enzymes like heparanase [6]. In preeclampsia, this is likely due to the pressures to deliver 
sulfate to the fetus. Preeclampsia is also associated with elevated serum levels of homocysteine [7–9], 
which is a precursor for sulfate synthesis. A deficiency in cobalamin is associated with elevated 
homocysteine levels [10] and with preeclampsia [9]. Cobalamin depletion is the key factor in 
pernicious anemia [11]. 
In this paper, we will present an argument that there is an intricate relationship among 
preeclampsia, pernicious anemia, autism and acute adverse reactions to vaccines, and, further, that all 
of these conditions are consequential to a preexisting severe deficiency in sulfate supply to the tissues 
and the vasculature. We are not claiming that vaccines cause autism, but rather that the appropriately 
predisposed child is especially vulnerable to an acute reaction to an aluminum-adjuvanted vaccine, 
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which could in rare cases lead to neuronal damage, mediated in part by exuberant production of nitric 
oxide. We support our arguments through a review of the research literature, as well as through a 
statistical study of word frequencies in various subsets of the VAERS database. We demonstrate a 
remarkable correspondence among symptoms in VAERS associated with autism, pernicious anemia, 
and preeclampsia, and we explain those symptoms as plausibly following from an acute reaction to 
blood instabilities brought on by an exuberant synthesis of nitric oxide by endothelial nitric oxide 
synthase (eNOS). 
In the remainder of this paper, we will first briefly introduce our hypothesis concerning a role for 
cholesterol sulfate insufficiency in autism. The next section will argue for a common underlying 
pathology in preeclampsia and anaphylactic reactions to vaccines. Section 4 discusses the association 
of autism with abnormal gut bacteria, and argues that this can lead to chronic excess NO synthesis. 
Section 5 links autism with preeclampsia through the shared feature of NO-induced seizures. Section 6 
discusses the potential role of mitochondrial DNA released by necrotic tissue in inducing an antigenic 
reaction. Section 7 proposes the hemolysis cascade that arises in certain contexts following 
provocation, which we believe is induced by instabilities in the blood coagulation system. Section 8 
discusses our studies with VAERS, which use statistical analyses of word frequencies to demonstrate a 
strong link among autism, preeclampsia, and pernicious anemia. Following a discussion section where 
we recapitulate our major findings, we end with a conclusion summarizing the main points of the paper. 
2. A Crucial Role for Cholesterol Sulfate and Endothelial Nitric Oxide Synthase 
Cholesterol sulfate is a very interesting molecule whose many biological roles are poorly 
understood [12]. In the third trimester of pregnancy, the placental villi are normally highly enriched in 
cholesterol sulfate [13]. We have argued that this placental cholesterol sulfate plays an important role 
in providing the fetus with adequate sulfate to populate the glycosaminoglycans (GAGs) in the 
extracellular matrix proteins in diverse cells throughout the body [5]. This is especially crucial for 
maintaining the zeta potential of the vasculature, in order to stabilize the colloidal suspension of blood 
particles [14]. This then places a huge demand on the mother. If her cholesterol sulfate levels are 
insufficient, the sulfate levels in the artery walls will be depleted and the RBCs’ and platelets’ ability 
to maintain adequate cholesterol sulfate in their membranes will be impaired, leading to hemolysis. 
The red blood cells play an essential role in the disease process. Crucially, cholesterol sulfate has been 
shown to protect them from lysis due to osmotic stress or viral attack [15,12]. 
RBCs are among the small number of cell types known to produce significant amounts of 
cholesterol sulfate [16]. Other cell types that produce it are platelets [17] and fibroblasts and 
melanocytes in the epidermis [18]. Intriguingly, all of these cell types also produce endothelial nitric 
oxide synthase (eNOS). Furthermore, mast cells, which produce large amounts of heparin, the most 
highly sulfated molecule known to biology, also contain eNOS. It has been known since 1927 [19] that 
prior administration of heparin protects from anaphylactic shock, and this is likely due to additional 
buffering of sulfate supplies. We have argued previously [5] that all of these cell types use eNOS 
predominantly to synthesize sulfate rather than NO, and that sunlight exposure catalyzes the reaction 
and supplies energy.  
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It is well established that calmodulin and caveolin regulate the activity of eNOS, where caveolin is 
associated with the membrane-bound form of eNOS attached at caveolae: a configuration we believe is 
responsible for the synthesis of sulfate [20]. Calcium entry into a cell, through a signaling mechanism 
that involves calcium-calmodulin binding, causes eNOS to detach from caveolin and catalyzes the 
synthesis of NO, following phosphorylation. Such calcium entry is triggered by TNF-α during an 
immune reaction. 
3. A Relationship between Disseminated Intravascular Coagulation and Vaccines? 
In this section, we describe the underlying process in acute preeclampsia that can result in a life-
threatening situation, developing as a consequence of insufficient sulfate buffering, and leading to 
serum colloidal instability and a complex reaction cascade involving profuse release of NO along with 
hemolysis of RBCs, ultimately developing into a profound crisis in the circulatory system and severe 
impairment in oxygen delivery. We argue that a similar process unfolds in an acute anaphylactic 
vaccine adverse reaction. 
Hemoglobin is a major scavenger of NO. In an extremely fast, irreversible, reaction (< 4 seconds 
reaction time) [21], nitrate and methemoglobin are produced, and this impairs oxygen delivery to the 
tissues; i.e., the effect is analogous to that of carbon monoxide [22]. Serum infusion of free 
hemoglobin solution results in hypertension. This is due to the reaction of NO with oxyhemoglobin in 
the blood circulation [23], which interferes with NO’s normal role, via the guanylyl cyclase pathway, 
in producing vasodilation [24]. Oxyhemoglobin reduces the half-life of soluble guanylyl cyclase from 
106 minutes to only 18 seconds [25]. Hemoglobin within red blood cells is 1,000-fold less reactive 
with nitric oxide than free hemoglobin, due in large part to the barrier of the RBC cell membrane. 
Under deoxygenated conditions this difference reduces to only 50-fold [26]. 
A case study of a patient who experienced a postpartum cascade leading ultimately to death 
illustrates the complex response associated with preeclampsia [27]. The patient presented with 
disseminated intravascular coagulopathy (DIC), resulting in a sudden rapid drop in platelet counts. The 
rapidly following consequences included blindness, severe abdominal pain, jaundice, and liver and 
kidney failure. Two seminal papers by Donald McKay describe the processes that ultimately lead to 
DIC [28,29], which are initiated by a precipitous destabilization of the blood colloidal system, 
followed by massive numbers of small clots formed from platelets in diverse organs, and with 
devastating consequences. It is triggered by a number of different agents, including bacterial 
endotoxins, particulate matter, proteolytic enzymes, anoxia, and hemolyzed RBCs. 
In [29] a phenomenon, associated with DIC, is described in which the synthesis of a fibrin mesh by 
platelets causes RBCs to be sliced into fragments, releasing their contents into the vasculature. We 
propose that this phenomenon offers protection from potentially toxic build-up of NO, produced in 
reaction to exposure to appropriate triggering factors (Selye provocation). The released hemoglobin 
would neutralize the NO by the rapid, irreversible reaction leading to methemoglobin and nitrate. The 
nitrate would be disposed of through the kidneys and the gut, and the methemoglobin would be broken 
down by macrophages through the action of heme oxygenase [30,31], which also suppresses the 
induction of cytokines. 
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Protamine sulfate, an L-arginine enriched protein, is used medically to reverse the anticoagulant 
effects of heparin. However, it can cause systemic hypotension, anaphylactoid reactions, and 
catastrophic pulmonary vasoconstriction. In [32], it is proposed that these effects are mediated by the 
profuse production of NO by endothelial cells, using the L-arginine in protamine as substrate. The 
hypotension induces an emergency cascade reaction that leads to hemolysis in order to release 
hemoglobin to rapidly neutralize the effects of NO on hypotension, thus inducing vasoconstriction 
instead of the vasodilation normally induced by NO. 
We consider an anaphylactic reaction to a vaccine to mimic in many respects the above cascade. In 
the case of a vaccine, the triggering factors are likely to include both endotoxin and aluminum. A 
reaction to an aluminum-containing vaccine could precipitate a crisis due to depletion of serum sulfate 
followed by excess build-up of NO. A study involving exposing mice to aluminum hydroxide and 
endotoxin demonstrated a significant and immediate synthesis of large amounts of NO in endothelial 
cells lining the artery walls [33], leading to anaphylactic shock. The authors were surprised to find that 
it was eNOS rather than iNOS (the inducible isoform) that was responsible for NO release.  
We hypothesize that aluminum plays a critical role in this effect. Aluminum binds to calmodulin 
with an affinity that is an order of magnitude higher than that of calcium [32]. Thus, the presence of 
even minute amounts of aluminum in the endothelial cells and RBCs would cause them to switch from 
producing sulfate to producing NO, resulting in both further depletion of sulfate supply and toxic 
build-up of NO in the blood stream [34]. 
In addition to the effect of switching eNOS from sulfate production to NO production, aluminum 
binds strongly to sulfate, and both molecules are strong kosmotropes, which are well known in colloid 
chemistry to promote the “salting out” of proteins [35]. In fact, aluminum sulfate is used as a 
flocculating agent in the purification of drinking water [36], for this reason. Furthermore, antigens, 
such as the dead or weakened pathogens or LPS in vaccines, also trigger increased production of NO, 
mainly mediated via iNOS (the inducible form), thus compounding the problem [37]. NO synthesis via 
iNOS is a key factor in killing invasive pathogens, mediated by its reaction with superoxide to  
produce peroxynitrite [38]. 
4. NO Synthesis and Gut Bacteria in Autism 
It has recently become apparent that the gut bacteria are a vast and diverse ecosystem [39], and 
abnormal gut biota have been proposed to play an important role in autism. [40,41]. All such bacteria 
are interactive and are known to affect the overall balance of the ecosystem in the gut. Autism is 
associated with gastrointestinal disturbances such as abdominal pain and bloating, as well as 
constipation and diarrhea [42,43], symptoms that are also commonly associated with pernicious anemia. 
Others have specifically investigated the distributions of intestinal bacteria flora in autistic 
individuals compared to normal controls, and these efforts have borne fruit. Most significant is the 
unusually high content of a sulfate-reducing bacterium (SRB) called Desulfovibrio, found in 50% of 
autistics examined and in none of the controls [44]. Since this anaerobe is resistant to penicillin, it 
would likely gain an advantage following penicillin treatment. However, there are further reasons for it 
to flourish in the context of excess bioavailability of nitrates. Desulfovibrio can metabolize both sulfate 
and nitrate, whereas nitrate is toxic to many other intestinal flora, particularly the methanogenic 
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bacteria (MB). A direct quote from [45, p. 246] is highly relevant: “The relative insensitivity of SRB to 
the toxic effects of nitrate or its reduction product, nitrite, compared with MB, suggest that nitrate 
could potentially play a role in selecting for SRB in the large gut.” 
In an experiment where gut bacteria were grown in culture under controlled conditions, it was found 
that the addition of gastric mucin had profound effects on the distribution of the bacteria in culture, 
leading to a large increase in the number of sulfur-reducing bacteria, at the expense of the 
methanogenic bacteria [46]. The authors attributed the effect to the release of sulfate from the 
polysaccharides in the mucin. Thus, if the GAGs in the gut lining are broken down by inflammatory 
agents, significant sulfate supply from the degraded mucins would maintain the excess presence of 
Desulfovibrio in the gut biota. 
Childhood inflammatory bowel disease is associated with an excess of nitrate and nitrite in both the 
stool and the serum [47], and inflammatory bowel disease is also associated with an overgrowth of 
Desulfovibrio [48]. Most significantly, excess plasma nitrate and nitrite are also found in association 
with autism [49–52]. It has been demonstrated that depletion of the sulfate in the intestinal GAGs is 
associated with both colitis and Crohn’s disease [53]. The breakdown of sulfated GAGs in the gut by 
Desulfovibrio likely plays a role in depleting the gut lining of sulfate, further aggravating the problem 
by compromising the gut barrier function. This also results in an increased penetration of endotoxins 
generated by this gram-negative bacterium through the leaky gut, which would further stimulate the 
synthesis of nitric oxide in a positive feedback loop [54,55], as schematized in Figure 1. Indeed, serum 
endotoxin levels are significantly elevated in autism and are inversely correlated with socialization 
skills [56]. 
Figure 1. Feedback loop leading to excess production of nitric oxide and Desulfovibrio 
overgrowth in the gut in autism, resulting in inflammatory bowel disease.  
 
How might nitric oxide synthesis be triggered in preeclampsia? In preeclampsia, the serum levels of 
corticotropin-releasing hormone (CRH) are elevated, and it has been shown that this has a direct effect 
on eNOS in the placental villi, leading to both upregulation of eNOS synthesis and increased 
production of nitric oxide by eNOS [57]. Furthermore, a key feature of the third trimester of pregnancy 
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is a sharp rise in the levels of progesterone in the blood stream. One of the well-known properties of 
progesterone is that it interferes with the storage of cholesterol in cells, and it therefore causes them to 
give up their cholesterol to the medium [58]. It could be argued that this feature is beneficial to the 
fetus because it frees up an additional supply of cholesterol for its use. However, cholesterol depletion 
from cells that are already deficient leads to ion leaks [59], which will eventually deplete ATP, as the 
cell has to consume a great deal of energy maintaining the ion gradients for sodium and potassium. A 
drop in ATP activates the ATP-sensitive potassium channels [60,61], which hyperpolarize the cell, 
leading to calcium entry [62]. This then stimulates eNOS to produce nitric oxide [20] via calmodulin-
calcium binding. It has been demonstrated in in vitro experiments that progesterone activates eNOS by 
stimulating phosphorylation within 30 minutes of exposure, and that this effect is mediated by the 
PI3K/Akt pathway [63,64]. 
It has been observed that preeclampsia is associated with an increased presence of fetal erythrocytes 
as well as cell-free fetal DNA in the maternal blood stream [65]. In [66], it is proposed that the cell-
free DNA is most likely of placental origin, and reflects damage to the placenta. The presence of such 
DNA in the blood stream could stimulate the mother’s immune system, causing oxidative stress and 
damage to the endothelial wall [67,68], a subject to which we will return in Section 6. The resulting 
inflammatory cascade, triggered by TNF-α release, would induce a profuse synthesis of nitric oxide, 
mirroring the feedback effects observed in autism when endotoxin is released by Desulfovibrio. We 
suggest that the placental damage may be similar to the damage to the glomeruli of the kidneys 
observed in preeclampsia, as well as the damage to the lining of the digestive tract in autism, both of 
which are due to excess depletion of sulfated GAGs. 
5. Autism, Nitric Oxide and Seizures 
It has recently been demonstrated, through longitudinal studies spanning the ages from six months 
to 24 months, that autistic brains exhibit a pathology in the development of white matter, particularly 
the anterior thalamic radiation fibers connecting thalamic nuclei to the cerebral cortex [69]. In vitro 
studies have demonstrated that, when neurons, oligodendrocytes, and astrocytes are exposed to nitric 
oxide, the neurons are more susceptible to damage than the glial cells, and, furthermore, it is 
specifically the axons in the neurons (white matter) that suffer the most damage [70]. This suggests 
that excess NO exposure may be the source of damage to the white matter associated with autism. In 
vitro experiments with rat optic nerve have demonstrated that NO is highly toxic to axons, producing 
both degeneration and persistent swelling [71]. Such damage, which could explain the visual 
dysfunction associated with both preeclampsia and pernicious anemia, is irreversible, but is inhibited 
by the NO scavenger, oxyhemoglobin [70]. 
Given the hypothesis that autism is associated with excess nitric oxide synthesis, it thus becomes 
plausible that the white matter associated with the thalamus, which is situated in a region of the brain 
that is less protected than most other parts by the blood brain barrier, might be especially vulnerable to 
exposure to excess nitric oxide from the blood. It might also be the case that the endotoxins released 
into the blood across the leaky gut have gained access to this vulnerable part of the brain, triggering 
nitric oxide synthesis by nNOS in these cells as a consequence of a cytokine response to the endotoxin. 
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Preeclampsia can in rare cases evolve into eclampsia, with the key differentiating feature being the 
onset of seizures. Seizures are also associated with autism, particularly in early childhood [72]. During 
epileptic seizures, calcium-dependent activation of eNOS and nNOS results in an increase in NO 
formation [73,74]. In [75], it was argued that NO-dependent enhancement of synaptic transmission is a 
key promoting factor in seizure initiation. NO, in part through its conversion to peroxynitrite, also 
inhibits mitochondrial electron transport [76,77], which could contribute to the metabolic impairment 
seen in the hippocampus in association with epilepsy [78,79]. Metabolic impairment due to 
mitochondrial dysfunction is identified as a key factor in epileptic seizures [80] and has also been 
found in association with autism [81]. 
6. Necrosis and Autoimmune Reactions 
Aluminum adjuvant (alum) plays an important role in vaccines by boosting adaptive immunity, and 
there are a number of hypotheses explaining probable mechanisms [82–85]. One explanation is the 
"depot effect" [82], whereby alum retains antigen at the injection site. A second explanation is that alum 
binds with antigen, producing insoluble alum-antigen aggregates that enhance immunogenicity [83]. A 
third idea, for which there is substantial evidence, is that it induces additional inflammatory agents, 
particularly nitric oxide, which cause cellular distress to the point of necrosis, mediated in part through 
the highly reactive peroxynitrite produced as a reaction product of NO with superoxide. Dying cells 
release uric acid as a catabolic product of purines in nucleotides [86], and uric acid is known to induce 
an immune response even in the absence of antigenic stimuli [87].  
We predict that aluminum would induce excess nitric oxide, at the expense of sulfate, due to its 
strong ability to bind calmodulin and emulate the effect of calcium on NO synthesis by eNOS. Indeed, 
in [84], an exuberant production of both NO and uric acid was induced in mouse experiments, 
following injection of alum alone or alum plus antigen, measured at 4 days, 7 days, and 10 days post 
injection. Autism is associated with elevated levels of nitrate in the blood stream [49–52], and 
aluminum likely plays a role in the excess nitrate production. In the study on aluminum and uric acid 
mentioned previously [84], it was shown that, in addition to inducing uric acid synthesis, aluminum 
administered parenterally also led to a profusion of NO synthesis. Abnormally high levels of aluminum 
were recently found in hair analyses of over half of 34 autistic children analyzed [88].  
It is likely that the immune response triggered by necrotic cells is induced by mitochondrial DNA 
released into the surrounding tissues. Mitochondrial DNA resembles bacterial DNA due to 
evolutionarily conserved similarities between the two. An interesting hypothesis to explain 
preeclampsia [89] proposes that the observed elevated serum levels of mitochondrial DNA associated 
with preeclampsia may be due to excessive necrosis of trophoblast cells in the placenta, consequential 
to placental inflammation. This in turn stimulates TLR9 to mount an immune response, leading to 
vascular dysfunction and hypertension. These authors suggest that this effect may apply more 
generally to any circumstance associated with abnormal cell death, and thus it would fit well as a 
hypothesis for alum-mediated adverse reactions as well. TLR9 is known to be specifically responsive 
to bacterial DNA antigen [90]. Thus, the response to mitochondrial DNA may be due to strong 
homology with bacterial DNA. Children with inflammatory bowel disease may have been primed by 
prior exposure to bacterial DNA in the gut wall lining. 
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Recently, attention has been drawn to the aluminum in vaccines as a potential neurotoxin on par 
with mercury [91]. Aluminum has been identified as a factor in chronic fatigue syndrome [92], and it is 
known to have extensive negative impact on the brain [93–101], if it cannot be properly disposed of by 
the body. Patients with macrophagic myofasciitis often experience cognitive and memory deficits in 
addition to chronic fatigue. For these patients, vaccine-derived aluminum hydroxide can persist long-
term in the brain in association with chronic cognitive dysfunction [95]. Recent experimental studies 
have confirmed that nanosized aluminum-containing particles are phagocytosed by macrophages and 
can be transported into the brain via the lymph nodes in a Trojan horse mechanism [97], and this 
mechanism was proposed to explain observed cognitive dysfunction in association with aluminum-
induced macrophagic myofasciitis. In a mouse model, alum brain levels peak 2-3 days following 
injection of alum adjuvants [102]. 
Recently, an entire issue of the journal Lupus was devoted to the topic of Autoimmune Syndrome 
Induced by Adjuvants (ASIA) [96]. Aluminum adjuvant in vaccines was one of the key triggering 
factors considered to enhance symptoms of autoimmune diseases such as lupus, likely mediated by the 
effects describe above. It is well established that autism is associated with abnormal immune function 
[103], which we argue is initiated through dysbiosis in the gut consequential to sulfate depletion, but 
enhanced by aluminum adjuvants. 
Figure 2 schematizes a proposed common mechanism mediated by either placental debris or debris 
from cells damaged by aluminum exposure at the injection site of a vaccine, leading to neuronal 
damage due to exuberant expression of nitric oxide, in the context of a prior severe deficiency in sulfate. 
Figure 2. Schematic of the common pathway by which preeclampsia and an acute reaction 
to a vaccine may induce a similar outcome, in the context of severe sulfate deficiency. 
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7. The Hemolysis/Nitric Oxide Synthesis Cascade  
RBCs play a critical role in the transport of oxygen and carbon dioxide: crucially, they shield the 
other elements in the blood from the strong oxidizing effects of oxyhemoglobin. When hemolysis 
occurs, hemoglobin enters the blood stream and the oxidizing potential of the exposed iron will further 
compromise the cell membranes of neighboring cells through the Fenton reaction, resulting in a 
dangerous cascade effect. Extreme vaccine adverse reactions exhibit a complex array of signs and 
symptoms which we argue can be explained by the cascade effect following upon the induction of 
hemolysis by aluminum, antigens, endotoxin, and nonionic surfactants such as Tween 80 and Triton 100. 
By “extreme adverse reaction,” we mean outcomes such as death, life-threatening heart issues, loss of 
consciousness, seizures, narcolepsy, ischemic thrombohemorrhagic events, etc. 
Hemolysis and nitric oxide synthesis can work together to produce nitrates in the blood stream, 
negatively charged ions that may partially compensate for the loss of sulfate in restoring zeta potential. 
This also constitutes a switch from kosmotropic to chaotropic anions, in an attempt to balance out the 
highly kosmotropic cation, aluminum [104]. However, the exuberant production of NO and release of 
oxyhemoglobin associated with a vaccine reaction is an out-of-control process with high risk of 
collateral damage. 
An excellent review of the clinical sequelae of hemolysis and excess synthesis of NO is provided in 
[105]. NO release will ultimately lead to a neutralization of the oxidizing potential of the free 
hemoglobin, through its conversion to methemoglobin. The reaction rate is enhanced 1,000-fold in free 
hemoglobin compared to hemoglobin sequestered inside RBCs [26]. Widespread hemolysis of RBCs 
ultimately results in a severely impaired ability to deliver oxygen to the tissues, and this can have life-
threatening consequences. Macrophages come into play to ingest the accumulating neutralized 
methemoglobin and break it down via heme oxygenase 1 (HO1), producing carbon monoxide, free 
iron, and bilirubin from the oxyhemoglobin [30]. Endotoxin further enhances the production of heme 
oxygenase by macrophages. 
There is a known association between excess bilirubin manifested as jaundice and autism. In a 
study conducted in Denmark, where sunlight availability in the winter months is scarce, infants with 
postnatal hyperbilirubinemia had nearly a four-fold increased risk to autism [106], and this effect was 
most pronounced for infants born in the winter months [107]. Treatment for jaundice involves sunlight 
or UV light therapy, which would lead to an increased production of cholesterol sulfate in the skin, 
thus ameliorating the deficit. 
Another way in which the NO is likely to be neutralized is through reaction with cobalamin, leading 
to the formation of nitrosylcobalamin. In experiments with mice, it was demonstrated that mice 
overproducing NO as a result of exposure to endotoxin eliminated nitrosylcobalamin via the urine [108]. 
The authors concluded that cobalamin can bind NO and quench its effect. But this will result in a 
severe depletion of serum cobalamin, leading directly to pernicious anemia. Furthermore, cobalamin 
deficiency itself seems to provoke hemolysis, further compounding the problem [109]. NO’s reaction 
product with superoxide, peroxynitrite, also reacts with cobalamin [110]. 
The reaction cascade is schematized in Figure 3. Importantly, our model predicts that a precondition 
associated with sulfate deficiency and chronic over-production of NO by eNOS leads to a disruption of 
gut bacteria and a heightened susceptibility to an anaphylactic reaction to an aluminum-adjuvanted vaccine. 
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Figure 3. Schematic of the reaction cascade associated with aluminum adjuvant exposure 
following a preexisting sulfate deficiency and gut dysbiosis, leading to pernicious anemia. 
 
8. Experiments with VAERS 
The Vaccine Adverse Event Reporting System (VAERS) is an on-line database, freely accessible, 
maintained by the CDC, where doctors and patients can report any notable adverse reactions to 
vaccinations. Data have been accumulating since 1990, and, to date, there are over 340,000 recorded 
events. This database is a valuable resource for researchers interested in finding associations among 
diverse signs and symptoms, which can then be compared against the research literature to identify 
probable biological explanations for the observed symptom complex. Many of the records also contain 
a detailed account of the temporal sequence of the development of individual symptoms; e.g., that 
pallor was followed by loss of consciousness, and nausea appeared ten minutes later. Many of the 
VAERS reports also include diagnostic lab-analyses reports and medical expert diagnoses. 
We have previously developed a strategy for identifying salient symptoms in selected subsets of a 
drug side effect database, based on a tabulation of word and phrase frequencies. The methods, detailed 
in [111,112], utilize log likelihood ratios to compute the likelihood that a given distribution of a word 
would have occurred by chance, and to provide a p-value for the confidence level of the observed 
skewed distribution. Given a pre-defined ontology of features, we analyze which features are strongly 
associated with a certain data set, using a standard computer science methodology, the log-likelihood 
ratio algorithm [112]. In statistics, a likelihood ratio test is used to compare the fit of two models, one 
of which (the null model) is a special case of the other (the alternative model). The test is based on the 
likelihood ratio, which expresses how many times more likely the data are under one model than the 
other. This likelihood ratio, or equivalently its logarithm, can then be used to compute a p-value to 
decide whether to reject the null model in favor of the alternative model. The results are normally 
considered as statistically significant when the p-value is less than 0.05. All of the results reported in 
this paper show p-values less than 0.05, and most are substantially below that number. 
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Our methods first involve selection of a targeted set that contains a specified set of words or 
phrases, and then producing a comparison set sampled from the remainder of the records (those not 
containing these words or phrases). The sampling is done with a sample bias that preserves the age 
distribution of the target set. Both sets then contain equal numbers of records, distributed the same way 
by age, but with all instances of the targeted words or phrases occurring in the targeted set. A process 
is then used to assign groups of words or phrases to specific symptom classes in order to gain 
statistical power. For example, “abdominal pain,” “abdominal discomfort,” “abdominal distention” and 
“abdominal tenderness” formed a common class representing abdominal pain. Importantly, each record 
only records a “0” or “1” count of each event class. Thus, if multiple references to abdominal pain 
occur under various fields in a given record, a count of “1” is added to the tally. A record with no 
mentions of words in a particular class gets a “0” count. 
In what follows, we will discuss results for three distinct targeted sets. The first set simply contains 
all records where the words “autism” or “autistic” are mentioned in any of the “symptoms” fields or 
under “lab data” or “history.” This set allows us to detect reactions and conditions that are associated 
with autism. The second set was selected on the basis of a number of words and phrases known to 
express symptoms associated with anemia. The set of words and phrases we searched on are shown in 
Table 1. We also identified a set of symptoms associated with preeclampsia from PubMed Health [113], 
and examined the degree to which these symptoms were also over-represented in our anemia data set. 
The third set distinguishes between aluminum-containing and non-aluminum-containing vaccines, and 
we use it to determine whether aluminum enhances injection site reactions. Please note that we recognize 
that “symptom” is not quite the right terminology as an umbrella term for all the words we are studying. 
However, for brevity and convenience, we will adopt this word, consistent with its usage in VAERS. 
Table 1. Words and phrases selected as representative of signs and symptoms of pernicious anemia. 
Class Alternates 
diarrhoea diarrhea 
constipation  
fatigue lethargy; lack of energy 
light-headed light headed; faint 
appetite loss loss of appetite; reduced appetite 
pallor pale skin 
dyspnoea dyspnea; hypoventilation; shortness of breath 
swollen tongue  
depression  
loss of balance  gait disturbance 
numbness  tingling; paresthesia; prickling 
8.1. Common Symptoms Found in Association with Autism, Preeclampsia, and Anemia 
The relationships among anaphylaxis, preeclampsia, anemia, hemolysis, and vaccine toxicity are 
neither immediately obvious nor intuitive. However, when viewed under the theory presented here, 
and with the statistical methodology described here to ferret out the relationship, an almost self-evident 
pattern can be discerned. 
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Results from our analyses, illustrated in Tables 2, 3 and 4, are quite illuminating. First of all, it is 
satisfying that anemia itself comes out with extremely high bias towards the anemia data set (p = 
0.00074) even though it was not one of the search terms we indexed on. Table 2 shows all the words 
and phrases that were present in the autism dataset with a p-value less than 0.05. The corresponding p-
value for these words and phrases in the anemia dataset are aligned on the right hand side of the table. 
It is striking that the anemia profile predicts autism itself with a p-value of 0.00066. It also strongly 
predicts all the autism-related words: anxiety, infection, eczema, asthma, premature, and pneumonia. 
In [5] we discussed how these conditions can all be explained by a deficiency in the supply of 
cholesterol sulfate. 
Table 2. Signs and symptoms with a p-value < 0.05 in the autism data set, and the 
associated counts and p-values for the anemia data set (note: here and in subsequent tables, 
we use the word “symptom” as an umbrella term representing signs, symptoms, and 
conditions, consistent with the VAERS database usage of the term.). 
Symptom 
count: 
autism 
count: 
control 
p-value 
count: 
anemia 
count: 
control 
p-value 
anxiety 49 2 0.01 1720 728 6.78E-06 
infection 54 6 0.01 1015 354 2.20E-05 
autism - - - 206 28 0.00066 
ear infection 32 3 0.03 117 24 0.0053 
eczema 18 0 0.04 134 44 0.0096 
asthma 24 3 0.05 682 307 0.00054 
premature 20 1 0.05 75 24 0.024 
pneumonia 19 1 0.05 613 350 0.0035 
Table 3 shows count distributions between the anemia data set and its control set for a set of signs, 
symptoms and conditions that are associated with preeclampsia according to PubMed. Once again, all 
of these symptoms are strongly prevalent in the anemia data set. For example, several symptoms 
related to eye problems―vision blurred, visual impairment, eye irritation, and sensitivity to light―are 
significantly more common in the anemia data set than in the comparison set. 
Table 3. Signs and symptoms that occur with enhanced frequency in the anemia data set, 
compared with the control set, which are also known to be highly common in preeclampsia. 
Symptoms count: anemia count: control p-value 
nausea 8817 3088 4.20E-14 
headache 4495 1839 9.50E-10 
abdominal pain 945 146 8.30E-07 
anxiety 1720 728 6.70E-06 
pulmonary 453 113 0.00016 
vision blurred 420 129 0.00042 
visual impairment 258 54 0.00069 
facial swelling 288 162 0.015 
eye irritation 119 50 0.022 
sensitivity to light 70 11 0.011 
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The PubMed description of symptoms related to vision problems associated with preeclampsia 
states: “temporary loss of vision, sensations of flashing lights, auras, light sensitivity, spots, and blurry 
vision,” which corresponds well with our detected symptoms related to the eyes. It has been reported 
that nitric oxide may be a key contributor to damage in glaucoma, resulting in neurodestruction of the 
optic nerve due to the generation of peroxynitrite as a product of the reaction of NO with superoxide 
[114,115]. Thus, excess NO synthesis may also be the key contributor to the vision symptoms 
associated with preeclampsia and anaphylaxis. 
Finally, Table 4 shows a variety of other signs and symptoms that showed up with high significance 
in the anemia subset. We grouped these symptoms into five categories―brain and nervous system 
problems, heart problems, muscle problems, life-threatening events, and “other.” Severe reactions like 
seizure, heart failure, heart rate irregularity, myalgia, dysphagia, paralysis, loss of consciousness and 
death are all significantly represented in the anemia data set. 
Table 4. Other signs and symptoms that were identified as highly significantly over- 
represented in the anemia data set, besides those specifically associated with autism  
or preeclampsia. 
Symptom count: anemia count: control p-value 
Brain and Nervous System Problems 
sleep disorder 534 140 0.000097 
seizure 1144 632 0.00047 
nerve injury 69 0 0.0042 
disorientation 112 32 0.01 
Heart Problems 
Symptom count: anemia count: control p-value 
chest pain 1366 278 2.00E-07 
heart rate irregular 963 279 1.00E-05 
heart failure 64 8 0.011 
Muscle Problems 
Symptom count: anemia count: control p-value 
myalgia 981 416 0.000096 
paralysis 384 71 0.00013 
dysphagia 353 96 0.0005 
Life Threatening Conditions 
Symptom count: anemia count: control p-value 
loss of consciousness 832 447 0.001 
death 180 74 0.01 
Other 
Symptom count: anemia count: control p-value 
swollen tongue 1116 322 0.0000044 
pulmonary 453 113 0.00016 
red blood cell 361 109 0.00065 
drooling/foam 123 32 0.007 
lymph node pain 219 107 0.013 
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Due to their high oxygen demand, the skeletal muscles and nervous system are especially 
susceptible to damage from anoxia, which is a direct consequence of the cascade triggered by 
overabundant synthesis of nitric oxide and excess hemolysis of RBCs. Responses such as loss of 
consciousness and paralysis are likely a direct consequence of a signaling cascade that shuts down 
oxygen supply, for example through pulmonary hypertension, in order to prevent further damage to 
lipids in cell membranes from exposure to oxidized iron and peroxynitrite. NO plays an essential role 
as a mediator of neuronal death during anoxia [116]. 
We believe that the effects of the cascade launched by a switch from sulfate to NO synthesis by 
eNOS is especially damaging to newborns and infants. Infants are especially susceptible to cyanosis 
due to exposure to nitrates and nitrites in well water [117], which are not however damaging to older 
children. Furthermore, administration of ethyl nitrite to infants has been demonstrated to induce acute 
methemoglobinemia and anoxia, resulting in sudden death [118], thus suggesting that the NO 
synthesized in the acute response of a severe adverse reaction to vaccines can be fatal. 
The results of our studies are summarized in Figure 4. The alignments among symptom sets 
uncovered automatically through these statistical analyses are remarkable. Additional symptoms 
derived from a database subset obtained by filtering on the symptom set associated with anemia predict 
not only anemia itself, but also autism, a symptom set intersecting with the set produced from the 
autism dataset, and a symptom set that well describes preeclampsia, including many of the unusual 
effects on vision.  
Figure 4. Schematic of discoveries arising from our studies of selected subsets of the 
VAERS database. 
 
8.2. Effects of Aluminum in Vaccines 
Table 5 quantifies the effects of aluminum in vaccines, independent of other factors such as antigen 
and LPS, in association with symptoms of anemia. To produce this table, we separated the anemia data 
set into two subsets: one representing vaccines known to contain aluminum and the other representing 
those known not to contain aluminum. We discarded records associated with the vaccines, HiB-titer, 
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Anthrax, and Rabies, because the literature is ambiguous regarding their aluminum content. The table 
shows only those symptoms with a p-value < 0.02. “Sleep disorder”, “fatigue”, “joint pain”, 
“depression”, “pain”, “infection” and “seizure” all had a significant count bias towards the aluminum-
containing subset. We feel that this result is highly intriguing, particularly the relationship with 
seizures. Due to its enhanced binding to calmodulin, we would expect aluminum to further promote 
nitric oxide exposure in the brain, and subsequent seizures. Future work will involve research to better 
explain the association of aluminum with these symptoms, many of which suggest involvement of 
muscles and neurons. 
Table 5. Signs and symptoms that were highly over-represented in the reports involving 
aluminum-containing vaccines (p-value < 0.02) compared to the non-aluminum containing 
vaccines, obtained by partitioning the anemia data set into two distinct subsets. 
Symptom count: aluminum count: not aluminum p-value 
sleep disorder 224 86 0.0051 
fatigue 2262 1817 0.006 
joint pain 495 291 0.0066 
depression 319 175 0.011 
pain 2008 1658 0.013 
infection 329 192 0.014 
seizure 536 369 0.018 
In order to determine whether aluminum might induce an increased reaction at the injection site, we 
collected two age-matched datasets drawn from the entire VAERS database, each containing nearly 
150,000 records, where one set concerned only non-aluminum containing vaccines and the other 
concerned only aluminum-containing vaccines. The two sets were matched for age distribution. We 
selected a set of phrases representing redness or discoloration at the injection site, such as “injection 
site macule” or “vaccination site erythema” and a set of phrases representing "injection site reaction" 
such as “local swelling” or “vaccination site inflammation”. These two classes were over-represented 
in the aluminum-containing set with p-values of 0.00000023 and 0.000017 respectively. This aligns 
with the hypothesis that aluminum achieves its adjuvant effects in part by stimulating a stronger 
immune reaction at the injection site, either by retaining the antigen complex in the site, by inducing 
profuse NO synthesis by eNOS, or by causing an enhanced immune response due to necrosis of 
localized tissues. This therefore also supports the idea that cell necrosis following aluminum exposure 
could lead to an autoimmune reaction due to mimicry of bacterial DNA by mitochondrial DNA, as 
previously discussed.  
No vaccine has been specifically approved by the FDA for use during pregnancy in the United 
States, yet vaccines are being given to pregnant women. Gardasil, in particular, is of grave concern, as it 
is given specifically to women in their reproductive years, and it contains aluminum hydroxide [119,120]. 
It has been demonstrated that even ultra-low doses of endotoxin infused into pregnant rats mimics the 
predominant features of preeclampsia [121]. Since preeclampsia can lead to stillbirths, we investigated, 
using our log likelihood tools, the relative risk to spontaneous abortion in Gardasil records from the 
VAERS database compared to age-matched controls. Our analysis showed 200 spontaneous abortions 
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or stillbirths for Gardasil as against only 18 for the sampled age-matched control database  
(p = 0.00044). Even if 18 is doubled to account for the gender bias, this is still a highly significant result. 
9. Discussion 
In this paper, we have developed an argument supporting a link among preeclampsia, autism, 
pernicious anemia, and anaphylactic shock, and have proposed that all of these conditions arise due to 
a deficiency in the supply of cholesterol sulfate to stabilize the colloidal suspension system of the 
blood. In a hypothesis put forth in a previous paper [5], we argued that the cholesterol sulfate supply is 
normally maintained by eNOS, acting in the epidermis, the endothelium, and the suspended blood 
cells, and that it requires the substrates cholesterol and sulfur, as well as sunlight, to provide the 
necessary activation energy for the reaction. Because cholesterol sulfate is the major source of both 
cholesterol and sulfate to a fetus, a pregnant woman can develop a major deficiency towards the end of 
the pregnancy. The association of preeclampsia with proteinuria reflects a raid on the sulfate in the 
GAGs in the glomeruli of the kidneys, to supply the fetus. 
Through careful study of the literature on autism, we have developed the hypothesis that excess 
synthesis of NO by the endothelium characterizes this condition, and explains the damage to axons in 
the brain associated with impaired cognitive abilities. We propose a feedback mechanism by which an 
overgrowth of Desulfovibrio in the gut leads to a destruction of the gut barrier through sulfate 
depletion. This in turn allows the endotoxins released by Desulfovibrio to enter the bloodstream, 
triggering an immune reaction and subsequent increase in NO synthesis, completing the feedback 
cycle. The excess NO synthesis by eNOS is necessarily associated with an impoverished synthesis of 
sulfate, as eNOS, according to our hypothesis, is a dual-purpose enzyme, which switches between 
nitric oxide and sulfate depending on the environment. Aluminum-containing vaccines are 
problematic, not only because aluminum causes eNOS to switch from sulfate to nitric oxide 
production, but also because aluminum can induce necrosis of tissues at the vaccination site, emulating 
the process of tissue damage to the placenta in preeclampsia. In both cases, the release of 
mitochondrial DNA into the blood stream may trigger an acute autoimmune reaction.  
This paper focuses on the sequence of events following an anaphylactic-shock-like reaction to 
vaccination, and shows how these symptoms share a common basis with symptoms of preeclampsia, 
autism, and pernicious anemia. The aluminum, present in many vaccines, such as hepatitis A and B, 
DTaP, and Gardasil, is a major contributor to the crisis, through its ability to bind and inactivate 
available sulfate. It also induces a switch from sulfate to nitric oxide synthesis on the part of eNOS, 
acting as a potent analog to calcium. Aluminum damage to cells at the reaction site can induce 
necrosis, resulting in the release of uric acid and mitochondrial DNA into the vasculature, paralleling 
the autoimmune reaction to a damaged placenta. 
The pathological response is initiated in the vascular system. An abundant and near instantaneous 
synthesis of NO results in an immediate precipitous drop in blood pressure. A reaction cascade triggers 
the release of coagulation factors, resulting in the widespread release of a fibrin matrix, which slices 
open trapped RBCs, liberating their contents into the blood serum. Eventually the released 
oxyhemoglobin will quench the excess NO, forming, irreversibly, methemoglobin and nitrate. 
Cobalamin also quenches NO, while simultaneously disabling cobalamin’s ability to function in its 
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catalytic roles. This leads to a severe cobalamin deficiency and the resulting symptoms of pernicious 
anemia [122]. 
Our studies of the signs and symptoms associated with anemia in the VAERS database revealed a 
concomitant symptom complex that is well explained by the above cascade of events. Furthermore, the 
data set associated with the symptoms of pernicious anemia also yielded a strong signal for all of the 
symptoms that are associated with autism, as well as autism itself. This link between anemia and 
autism is not intuitive—it is established based on statistical analyses of the symptoms found in the US 
CDC VAERS database, notwithstanding its flaws—underreporting and selection bias. 
In a previous paper [5], we explained how several signs and symptoms found in association with 
autism—eczema, asthma, premature birth, and digestive disorders—could all be attributed to a 
deficiency in the supply of cholesterol sulfate. Thus, the increased susceptibility to a serious vaccine 
reaction associated with autism in the VAERS database is likely tied to increased vulnerability to a 
crisis in colloidal stability in the blood induced by the additional load of the vaccine-supplied toxins to 
an already vulnerable blood system. 
Aluminum-containing vaccines, compared to non-aluminum-containing vaccines, show an 
increased incidence of sleep disorder, depression, and seizures, in association with the anemia 
symptom complex. These are all potential indicators of penetration of the aluminum into the brain, as a 
direct consequence of an inability to properly dispose of the aluminum due to the sulfate deficiency. 
Aluminum’s negative impact on brain function is well established [93–101]. 
Finally, we argue that preeclampsia, itself a strong predictor of future autism in the fetus, is a 
manifestation of the same reaction cascade associated with an extreme adverse reaction to vaccines. 
The cholesterol sulfate depletion, in this case, is a direct consequence of the enhanced needs for this 
critical nutrient by the developing fetus, in the context of an existing nutritional deficiency in the 
mother. An aluminum-containing vaccine, administered late in pregnancy to a woman already 
predisposed to preeclampsia, will likely precipitate an acute event, leading to miscarriage or stillbirth, 
a concept that is supported by an analysis of spontaneous abortion rates for Gardasil in the VAERS 
database. 
10. Conclusions 
We have proposed in this paper a novel hypothesis for the underlying pathology that links 
preeclampsia, autism, pernicious anemia and extreme adverse reactions to vaccines. In all cases, we 
suggest that a deficiency in the supply of cholesterol sulfate to the tissues creates a vulnerability to 
environmental toxins, which precipitates the pathological response. Excess NO synthesis by nitric 
oxide synthases provokes a cascade response with devastating consequences. Severe cobalamin 
depletion due to its reaction with NO and NO metabolites, along with extensive hemolysis of red blood 
cells, manifests as symptoms of classic pernicious anemia, and the sequelae can lead to death. We have 
used statistical analysis of the VAERS database to support our hypothesis. Further research will be 
needed to either confirm or disprove our hypothesis. If it is valid, then we propose that an effective 
prevention program for this pathology might simply require enhanced dietary intake of sulfur-
containing amino acids and greater sun exposure to the skin. We would also recommend the 
elimination of aluminum as an adjuvant in vaccines. 
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